BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15834437)

  • 1. The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Kallianpur AR; Hall LD; Yadav M; Byrne DW; Speroff T; Dittus RS; Haines JL; Christman BW; Summar ML
    Bone Marrow Transplant; 2005 Jun; 35(12):1155-64. PubMed ID: 15834437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
    Sun X; Hao WG; Liu S; Xia T; Liao C
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumors.
    Bouligand J; Le Maitre A; Valteau-Couanet D; Grill J; Drouard-Troalen L; Paci A; Hartmann O; Benhamou E; Vassal G
    Clin Pharmacol Ther; 2007 Oct; 82(4):402-9. PubMed ID: 17392724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis gene mutations and distal adenomatous colorectal polyps.
    McGlynn KA; Sakoda LC; Hu Y; Schoen RE; Bresalier RS; Yeager M; Chanock S; Hayes RB; Buetow KH
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):158-63. PubMed ID: 15668490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?
    Kallianpur AR
    Bone Marrow Transplant; 2005 Jan; 35(1):1-16. PubMed ID: 15489868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors.
    Alanen KW; Chakrabarti S; Rawlins JJ; Howson W; Jeffrey G; Adams PC
    Hepatology; 1999 Sep; 30(3):665-9. PubMed ID: 10462372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer.
    Abraham BK; Justenhoven C; Pesch B; Harth V; Weirich G; Baisch C; Rabstein S; Ko YD; BrĂ¼ning T; Fischer HP; Haas S; Brod S; Oberkanins C; Hamann U; Brauch H;
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1102-7. PubMed ID: 15894659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DMT1 genetic variability is not responsible for phenotype variability in hereditary hemochromatosis.
    Kelleher T; Ryan E; Barrett S; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2004; 33(1):35-9. PubMed ID: 15223008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Tefferi A; Kumar S; Wolf RC; Lacy MQ; Inwards DJ; Gloor JM; Albright RC; Kamath PS; Litzow MR
    Bone Marrow Transplant; 2001 Nov; 28(10):997-9. PubMed ID: 11753559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.
    Robinson G; Narasimhan S; Weatherall M; Beasley R
    J Gastroenterol Hepatol; 2007 Jun; 22(6):852-4. PubMed ID: 17565641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis.
    Sherrington CA; Knuiman MW; Divitini ML; Bartholomew HC; Cullen DJ; Olynyk JK
    J Gastroenterol Hepatol; 2006 Mar; 21(3):595-8. PubMed ID: 16638105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation.
    Qiao J; Fu J; Fang T; Huang Y; Mi H; Yang N; Chen C; Xu K; Zeng L
    Exp Mol Pathol; 2015 Feb; 98(1):73-8. PubMed ID: 25533545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
    Tanikawa S; Mori S; Ohhashi K; Akiyama H; Sasaki T; Kaku H; Hiruma K; Matsunaga T; Morita T; Sakamaki H
    Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique genetic profile of hereditary hemochromatosis in Russians: high frequency of C282Y mutation in population, but not in patients.
    Potekhina ES; Lavrov AV; Samokhodskaya LM; Efimenko AY; Balatskiy AV; Baev AA; Litvinova MM; Nikitina LA; Shipulin GA; Bochkov NP; Tkachuk VA; Bochkov VN
    Blood Cells Mol Dis; 2005; 35(2):182-8. PubMed ID: 16055358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE mutations and risk of coronary heart disease in middle-aged women.
    van der A DL; Peeters PH; Grobbee DE; Roest M; Marx JJ; Voorbij HM; van der Schouw YT
    Eur J Clin Invest; 2006 Oct; 36(10):682-90. PubMed ID: 16968463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine model of hepatic veno-occlusive disease induced by allogeneic hematopoietic stem cell transplantation.
    Zeng L; An L; Fang T; Pan B; Sun H; Chen C; Cao J; Li Z; Xu K
    Cell Biochem Biophys; 2013; 67(3):939-48. PubMed ID: 23579582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer.
    Kallianpur AR; Hall LD; Yadav M; Christman BW; Dittus RS; Haines JL; Parl FF; Summar ML
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):205-12. PubMed ID: 14973098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.